This is a renewal application for an interdisciplinary project to understand the biological barriers to protein and DNA transport at mucosal surfaces and to produce new polymeric delivery systems to enhance immune protection within the female reproductive tract. In the past periods of support, we demonstrated that: antibodies (Abs), other proteins, and DNA can be slowly released from biocompatible polymer matrices and microspheres; these agents are active at the mucosal surface;human Abs, plasmid DNA, and other macromolecules can diffuse as fast through human cervical mucus as they do through water;a polymer vaginal ring can continuously release active Abs or DNA that becomes well-distributed throughout the vaginal secretions of a mouse for 30 d;vaginal rings releasing anti-herpes Abs can prevent genital infections in mice and vaginal rings releasing antigens can stimulate a long-lasting, mucosal immune response to sperm antigens in the mouse;orally-administered polymer microparticles loaded with Vg can stimulate mucosal immunity in the vagina;surface modification of particles can influence local transport and antigen processing in dendritic cells;DNA delivered at the mucosal surface can transfect local cells, which leads to local immunity;and mucosal delivery systems that deliver DNA vaccines encoding SIV proteins can protect rhesus macaques from mucosal challenges of SIV. We now propose a novel modular approach to the design and synthesis of biodegradable nanoparticles, made from proven PLGA and from novel poly(?-pentadecalactone-co-p-dioxanone), using modular design to add multiple functions. Our experiments are designed to quantify the barriers to nanoparticle transport at these tissue sites, and to develop polymeric drug delivery systems that overcome the barriers. We propose the following interrelated specific aims: 1) Development and characterization of multifunctional nanoparticle delivery systems for peptides, DNA, and siRNA;2) Design of new and use of existing delivery systems to examine DNA delivery and siRNA delivery in the intestinal, respiratory, and reproductive tracts of the mouse;and 3) Testing of new delivery systems for treatment of SIV infection in rhesus macaques, the premier model of HIV infection in humans.

Public Health Relevance

Statement STDs and unwanted pregnancy create tremendous burdens on individuals, on U.S. society, and on the national health care costs. The work in this application will provide new approaches for preventing and treating STDs and preventing unwanted pregnancy. Specifically, we will test a new approach for treatment of HIV/AIDS infections. The approach will emphasize materials and approaches that can be translated into clinical products, which would provide new opportunities for enhancing health.

National Institute of Health (NIH)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Research Project (R01)
Project #
Application #
Study Section
Bioengineering, Technology and Surgical Sciences Study Section (BTSS)
Program Officer
Tucker, Jessica
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Yale University
Engineering (All Types)
Schools of Engineering
New Haven
United States
Zip Code
Fields, Rachel J; Quijano, Elias; McNeer, Nicole Ali et al. (2015) Modified poly(lactic-co-glycolic acid) nanoparticles for enhanced cellular uptake and gene editing in the lung. Adv Healthc Mater 4:361-6
Cheng, Christopher J; Bahal, Raman; Babar, Imran A et al. (2015) MicroRNA silencing for cancer therapy targeted to the tumour microenvironment. Nature 518:107-10
Martin, Darryl T; Steinbach, Jill M; Liu, Jingchun et al. (2014) Surface-modified nanoparticles enhance transurothelial penetration and delivery of survivin siRNA in treating bladder cancer. Mol Cancer Ther 13:71-81
Bahal, Raman; Quijano, Elias; McNeer, Nicole A et al. (2014) Single-stranded ?PNAs for in vivo site-specific genome editing via Watson-Crick recognition. Curr Gene Ther 14:331-42
Weiser, Jennifer R; Saltzman, W Mark (2014) Controlled release for local delivery of drugs: barriers and models. J Control Release 190:664-73
Deng, Yang; Saucier-Sawyer, Jennifer K; Hoimes, Christopher J et al. (2014) The effect of hyperbranched polyglycerol coatings on drug delivery using degradable polymer nanoparticles. Biomaterials 35:6595-602
Cheng, Christopher J; Saltzman, W Mark; Slack, Frank J (2013) Canonical and non-canonical barriers facing antimiR cancer therapeutics. Curr Med Chem 20:3582-93
Kobsa, Serge; Kristofik, Nina J; Sawyer, Andrew J et al. (2013) An electrospun scaffold integrating nucleic acid delivery for treatment of full-thickness wounds. Biomaterials 34:3891-901
McNeer, N A; Schleifman, E B; Cuthbert, A et al. (2013) Systemic delivery of triplex-forming PNA and donor DNA by nanoparticles mediates site-specific genome editing of human hematopoietic cells in vivo. Gene Ther 20:658-69
Cheng, Christopher J; Saltzman, W Mark (2011) Enhanced siRNA delivery into cells by exploiting the synergy between targeting ligands and cell-penetrating peptides. Biomaterials 32:6194-203

Showing the most recent 10 out of 28 publications